A Milestone in Facilitating the Development of Safe and Effective Biosimilars
The 50th biosimilar approval milestone also reflects our strategic approach to biosimilars, as outlined in the FDA ’s Biosimilars Action Plan.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Drugs & Pharmacology